title: Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
authors.forename: D P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: E S
authors.initials: ES
authors.lastname: Ganotakis
authors.forename: A F
authors.initials: AF
authors.lastname: Winder
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005340:Fibrinogen / Q000187:drug effects / Q000378:metabolism*; D005500:Follow-Up Studies; D018056:Hemorheology / Q000187:drug effects*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000188:drug therapy; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017035:Pravastatin / Q000627:therapeutic use*; D019821:Simvastatin
chemical_list: D000924:Anticholesteremic Agents; D005340:Fibrinogen; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin